SCHEMBL9589367

SCHEMBL9589367

CCC(C(=O)OC)c1ccc(OC)c(OC)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.55
CYP2C19 P33261 1/20 0.55
KCNQ2 O43526 1/20 0.51
LMNA P02545 2/20 0.50
ACHE P22303 1/20 0.49
PPARG P37231 1/20 0.49
PPARD Q03181 1/20 0.49
PPARA Q07869 1/20 0.49
AKR1C3 P42330 3/20 0.48
AKR1C2 P52895 3/20 0.48
AKR1C1 Q04828 1/20 0.48
PTGS1 P23219 1/20 0.48
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
GAA P10253 1/20 0.47
RECQL P46063 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HIF1A Q16665 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11582477 0.89 CA12 (0.52) ALDH1A1CYP2C19KCNQ2LMNAACHE
SCHEMBL31614252 0.88 ALDH1A1 (0.47) ALDH1A1CYP2C19KCNQ2LMNAAKR1C3
SCHEMBL11001026 0.87 ALDH1A1 (0.52) ALDH1A1CYP2C19KCNQ2LMNAACHE
SCHEMBL16865514 0.87 TAS1R3 (0.48) ALDH1A1CYP2C19KCNQ2LMNAACHE
SCHEMBL25304057 0.86 ALDH1A1 (0.49) ALDH1A1CYP2C19KCNQ2LMNAACHE
SCHEMBL6432599 0.85 PAX8 (0.53) ALDH1A1CYP2C19KCNQ2LMNAACHE
SCHEMBL3828059 0.85 AKR1C3 (0.65) CYP2C19KCNQ2LMNAACHEPPARG
SCHEMBL30990182 0.85 ACHE (0.54) ALDH1A1CYP2C19KCNQ2LMNAACHE
SCHEMBL9589600 0.85 PPARG (0.50) ALDH1A1CYP2C19KCNQ2LMNAACHE
SCHEMBL9000813 0.84 EPHX2 (0.48) ALDH1A1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5190946-A Piperazine compounds restore sensitivity to drug resistant cancer cells HOFFMANN-LA ROCHE INC. (US) 1993-03-02 US disclosed
EP-0443569-A2 Diamine derivatives and their use in oncology F. HOFFMANN-LA ROCHE AG (CH) 1991-08-28 EP disclosed